Natera (NTRA) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Natera Reports Second Quarter 2016 Financial Results
August 4, 2016 4:17 PM EDTSAN CARLOS, Calif., Aug. 4, 2016 /PRNewswire/ --Â Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the second quarter ended June 30, 2016 and provided an update on recent business progress.
Recent Accomplishments & Highlights
Generated total revenues of $52.0 million in the second quarter of 2016 compared to $45.1 million in the second quarter of 2015, an increase of 15% Accessioned greater than 103,000 tests in the second quarter of 2016 compared to approximately 69,000 tests accessioned in the second quarter of 2015, an increase... More


